Blockage of Central Sphingosine-1-phosphate Receptor does not Abolish the Protective Effect of FTY720 in Early Brain Injury after Experimental Subarachnoid Hemorrhage

Publisher： Bentham Science Publishers

E-ISSN： 1875-5704|14|6|861-866

ISSN： 1567-2018

Source： Current Drug Delivery, Vol.14, Iss.6, 2017-09, pp. : 861-866

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clazosentan: an endothelin receptor antagonist for treatment of vasospasm after subarachnoid hemorrhage

By Macdonald R Loch  

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 11, 2008-11 ,pp. : 1761-1767

Informa Healthcare

Access to resources Recommend Favorite

Sphingosine-1-Phosphate Receptors in the Central Nervous and Immune Systems

By  

Current Drug Targets, Vol. 17, Iss. 16, 2016-12 ,pp. : 1841-1850

Bentham Science Publishers

Access to resources Recommend Favorite

Sphingosine 1-phosphate receptor agonists: a patent review (2010 - 2012)

By Roberts Edward  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 7, 2013-07 ,pp. : 817-841

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Impact of Sphingosine 1-phosphate Receptor Signaling in Multiple Sclerosis

By  

Mini Reviews in Medicinal Chemistry, Vol. 16, Iss. 7, 2016-05 ,pp. : 547-554

Bentham Science Publishers

Access to resources Recommend Favorite

Synthetic Sphingosine 1-Phosphate Receptor Modulators - Opportunities and Potential Pitfalls

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 6, 2011-03 ,pp. : 726-757

Bentham Science Publishers

Access to resources Recommend Favorite